Laman UtamaSHTDY • OTCMKTS
add
Sinopharm Group ADR
Tutup sebelumnya
$12.97
Julat hari
$12.94 - $13.40
Julat tahun
$10.77 - $14.22
Permodalan pasaran
62.23B HKD
Bilangan Purata
42.34K
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 145.44B | -1.53% |
Perbelanjaan pengendalian | 6.37B | -6.94% |
Pendapatan bersih | 1.85B | 16.88% |
Margin untung bersih | 1.27 | 18.69% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 4.66B | 3.57% |
Kadar cukai berkesan | 24.66% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 38.77B | — |
Jumlah aset | 418.38B | — |
Jumlah liabiliti | 286.21B | — |
Jumlah ekuiti | 132.17B | — |
Syer tertunggak | 3.12B | — |
Harga kepada buku | 0.49 | — |
Pulangan pada aset | 2.46% | — |
Pulangan pada modal | 4.71% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.85B | 16.88% |
Tunai daripada operasi | -4.97B | 26.15% |
Tunai daripada pelaburan | 781.72J | -19.99% |
Tunai daripada pembiayaan | -4.04B | -162.10% |
Perubahan bersih dalam tunai | -8.22B | -12.59% |
Aliran tunai bebas | -1.34B | — |
Perihal
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Diasaskan
2003
Tapak web
Pekerja
100,251
